Jeremiah Kelly’s practice centers on helping companies navigate the complexities of the U.S. Food and Drug Administration’s (FDA) regulation of drugs, biologics, medical devices, and combination products. Jeremiah helps companies from “bench to bedside.” He supports companies along the development and commercialization pathway, from pre-clinical, clinical, and pre-market applications for FDA’s approval, licensure, clearance, or authorization of medical products to post-market compliance. Prior to joining Venable, Jeremiah served as the Chief of the FDA Regulatory Law Division in the Office of the Staff Judge Advocate (JAG), U.S. Army Medical Research and Development Command (USAMRDC).